Skip to main content

Table 1 Schedule of measures

From: The adherence/resource priming paradigm – a randomised clinical trial conducting a bonafide psychotherapy protocol for generalised anxiety disorder

Measures

Measurement waves

 

Ass.

Pre

Sess-by-Sess

Mid

Post

FU

Eligibility

Structured Interview for DSM (SCID) [62]

+

     

GAD-section of the (F-DIPS) [58]

+

     

GAD-criteria self-report [62]

+

     

WDQ [60, 61]

+

     

GAD-outcomes

Beck Anxiety Inventory (BAI) [63, 64]

 

+

1-15

+

+

+

Penn State Worry Questionnaire (PSWQ) [59, 60]

+

+

 

+

+

+

State –Trait Anxiety (STAI) [65, 66]

 

+

 

+

+

+

General-outcomes

Premature termination

  

1-15

   

Beck Depression Inventory II (BDI-II) [67, 68]

+

+

 

+

+

+

Brief Symptom Inventory (BSI) [69, 70]

 

+

 

+

+

+

BIS/BAS scales [71, 72]

 

+

 

+

+

+

Inventory of Interpersonal Problems (IIP-64) [73, 74]

 

+

 

+

+

+

Inventory of Interpersonal Strengths (IIS-64) [75, 76]

 

+

 

+

+

+

Resource potential questionnaire (RES) [75, 77]

 

+

 

+

+

+

Self-report process-measures

Working Alliance Inventory - Patient (WAI-P) [78, 79]

  

1-15

   

Working Alliance Inventory – Therapist (WAI-T) [78, 79]

  

1-15

   

Bern Post-Session Report – Patient (BPSR-P) [80]

  

1-15

   

Bern Post-Session Report – Therapist (BPSR-T) [80]

  

1-15

   

Video observer ratings

Adherence rating

  

2,5,8,11

   

Resource-oriented Microprocess Analysis – Patient (ROMA-P) [55]

  

2,5,8,11

   

Resource-oriented Microprocess Analysis – Therapist (ROMA-T) [55]

  

2,5,8,11

   

Level of explication [81]

  

2,5,8,11

   

Therapists’ measures

Inventory of Interpersonal Problems (IIP-64) [73, 74]

+1

     

Inventory of Interpersonal Strengths (IIS-64) [75, 76]

+1

     

Measure of Attachment Quality (MAQ) [82, 83]

+1

     

Therapists’ allegiance self-report

+1

     

Therapeutic Attitude Scale (TASC), therapeutic style section [84]

    

+2

 
  1. 1At the beginning of the study, 2At the overall end of the treatment.